The trinity of COVID-19: immunity, inflammation and intervention

Tay, Matthew Zirui, Poh, Chek Meng, Rénia, Laurent, MacAry, Paul A., Ng, Lisa F. P.·2020·Nature Reviews Immunology
DOI 10.1038/s41577-020-0311-8

Cited by (1,002)

Items 1,001–1,002 of 1,002

  1. Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
    Dobosh, Brian, Zandi, Keivan, Giraldo, Diego Moncada, Goh, Shu Ling, Musall, Kathryn, Aldeco, Milagros, LeCher, Julia, Giacalone, Vincent D., Yang, Junkai, Eddins, Devon J. et al. · 2022 · Cell Reports
  2. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
    Devaux, Christian A., Camoin-Jau, Laurence · 2022 · Frontiers in Microbiology